Maryland Prostate Cancer — Baltimore, Maryland

Maryland Prostate Cancer is a clinical research site located in Baltimore, Maryland, United States 21201.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Maryland Prostate Cancer has participated in 1 clinical trials.

Therapeutic areas: Urinary Retention, Prostatic Hyperplasia, Benign Prostatic Hypertrophy.

Sponsors: Sanofi.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Maryland Prostate Cancer?

Maryland Prostate Cancer has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Maryland Prostate Cancer conducted?

Maryland Prostate Cancer has 1 clinical trials on record. Their work covers Urinary Retention, Prostatic Hyperplasia, Benign Prostatic Hypertrophy.

Is Maryland Prostate Cancer accredited by Crixeo Health?

Maryland Prostate Cancer has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Maryland Prostate Cancer?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.